FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

273943001: Nicotinic acid (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
409651017 Antipellagra factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
666642013 Nicotinic acid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2153869018 Nicotinic acid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154891015 Niacin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
827891000172115 acide nicotinique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nicotinic acid (substance) Is a Water-soluble vitamin false Inferred relationship Some
Nicotinic acid (substance) Is a classe d'allergènes false Inferred relationship Some
Nicotinic acid (substance) Is a allergène médicamenteux false Inferred relationship Some
Nicotinic acid (substance) Is a Pyridine true Inferred relationship Some
Nicotinic acid (substance) Is a Vitamin B and/or vitamin B derivative (substance) true Inferred relationship Some
Nicotinic acid (substance) Is a Nicotinic acid and derivatives false Inferred relationship Some
Nicotinic acid (substance) Is a Nicotinic acid and derivatives false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental nicotinic acid derivative poisoning Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Intentional nicotinic acid derivative poisoning Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid derivative poisoning of undetermined intent Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid adverse reaction Causative agent (attribute) True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid derivative overdose Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some 1
Accidental nicotinic acid derivative overdose Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some 1
Intentional nicotinic acid derivative overdose Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid derivative overdose of undetermined intent Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing precisely nicotinamide 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
produit contenant du nicotinamide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing nicotinic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Niacinamide [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 750 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Lovastatin 20 mg and nicotinic acid 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing lovastatin and nicotinic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 375mg m/r tablet and nicotinic acid 500mg m/r tablet and nicotinic acid 750mg m/r tablet starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 750mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 1000mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid compound The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Accidental nicotinic acid derivative poisoning Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Intentional nicotinic acid derivative poisoning Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Allergy to nicotinic acid (finding) Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Poisoning by nicotinic acid derivative Causative agent (attribute) False Nicotinic acid (substance) Inferred relationship Some
Niacin measurement (procedure) Component True Nicotinic acid (substance) Inferred relationship Some 1
Serum nicotinic acid measurement (procedure) Component False Nicotinic acid (substance) Inferred relationship Some 2
Nicotinic acid 250 mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Lovastatin 40 mg and nicotinic acid 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing nicotinic acid and simvastatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Allergy to nicotinic acid (finding) Causative agent (attribute) True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 1 g oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 40 mg and nicotinic acid 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 40 mg and nicotinic acid 1 g oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some 2
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Nicotinic acid (substance) Inferred relationship Some 2
Providing niacin based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. Direct substance False Nicotinic acid (substance) Inferred relationship Some 1
Increase in niacin content of the diet compared to the assessed baseline intake of niacin for the individual. Direct substance True Nicotinic acid (substance) Inferred relationship Some 1
Increase or decrease in niacin content of the diet. Treatment for prevention of pellagra. Direct substance True Nicotinic acid (substance) Inferred relationship Some 1
Ethylnicotinamide This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Nicotinic acid (substance) Inferred relationship Some
Decrease in niacin content of the diet compared to the assessed baseline intake of niacin for the individual. Direct substance True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinamide (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Nicotinic acid (substance) Inferred relationship Some
Hexyl nicotinate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Nicotinic acid (substance) Inferred relationship Some
Xantinol nicotinate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid 375mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nicotinic acid (substance) Inferred relationship Some
Product containing precisely nicotinic acid 1 gram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 1 gram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 40 mg and nicotinic acid 1 g oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin 20 mg and nicotinic acid 1 g oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Lovastatin- and nicotinic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing nicotinic acid in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Morniflumate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Nicotinic acid (substance) Inferred relationship Some
Nicotinic acid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing only nicotinic acid and simvastatin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing only lovastatin and nicotinic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing only lovastatin and nicotinic acid in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 250 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotinic acid (substance) Inferred relationship Some 1
Nicotinic acid 250 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nicotinic acid (substance) Inferred relationship Some 1

Page 1 of 2 End


This concept is not in any reference sets

Back to Start